期刊文献+

CHO-DG44细胞瞬时转染条件的优化 被引量:2

Optimization of condition for transient transfection of CHO-DG44 cells
原文传递
导出
摘要 目的优化CHO-DG44细胞瞬时转染的条件。方法采用TubeSpin一次性生物反应器,以绿色荧光蛋白(Green fluorescence protein,GFP)为报告基因,氯醚酰亚胺(Polyether imide,PEI)为转染试剂,将质粒pIRESneo3-eGFP瞬时转染CHO-DG44细胞,优化瞬时转染的基本条件[细胞密度、DNA浓度和DNA:PEI比例(w/w)]以及其他条件(换液、渗透压和温度),采用优化的条件转染质粒pIRESneo3-eGFP,流式细胞术检测细胞转染效率,生物发光仪检测相对荧光强度。结果 CHO-DG44细胞瞬时转染的最佳条件为:采用XLG-P8培养基进行转染,细胞密度为2×106个/ml,DNA浓度为6.25μg/5 ml,DNA∶PEI(w/w)比例为1∶5;转染后4 h更换新鲜培养基,添加30 mmol/L NaCl,并于31℃继续培养。在此条件下,CHO-DG44细胞的瞬时转染效率可达81.45%,相对荧光强度可达9×105RFU/106cells。结论优化了CHO-DG44细胞瞬时转染的条件,为下一步药物蛋白的研发奠定了基础。 Objective To optimize the condition for transient transfection of CHO-DG44 cells.Methods CHO-DG44 cells were transiently transfected with plasmid pIRESneo3-eGFP in TubeSpin disposable bioreactor using green fluorescence protein(GFP) gene as a reporter and polyether imide(PEI) as a transfection reagent.The primary condition such as cell density,DNA concentration and ratio of DNA to PEI(w / w),as well as other conditions such as osmotic pressure and temperature for changing medium,were optimized.The cells were transfected with pIRESneo3-eGFP under the optimized condition,and determined for transfection efficacy by flow cytometry,and for relative fluorescent intensity by bioluminescence analyzer.Results The optimal medium,cell density,DNA concentration,ratio of DNA to PEI(w / w) for transient transfection of CHO-DG44 cells were XLG-P8 medium,2 × 10^6 cells / ml,6.25 μg / 5 ml and 1: 5 respectively.The culture was transferred to fresh medium 4 h after transfection,added with 30 mmol / L sodium chloride and further incubated at 31℃.Under the optimized condition,the transient transfection efficiency of CHO-DG44 cells reached 81.45%,while the fluorescent intensity was about 9 × 10^5 RFU / 106 cells.Conclusion The condition for transient transfection of CHO-DG44 cells was optimized,which laid a foundation of further development of pharmaceutical proteins.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第4期558-562,566,共6页 Chinese Journal of Biologicals
基金 国家"十二五"重大新药创制项目(2012ZX09202-301-001) 广东省产学研项目(2010B090400500) 暨南大学科研培育与创新基金(11612110) 广州市重大科技专项计划项目(2010U1-E00541) "重大新药创制"国家科技重大专项(2011ZX09506-006)
关键词 CHO-DG44细胞 转染 瞬时表达 优化 CHO-DG44 cells Transfection Transient expression Optimization
  • 相关文献

参考文献22

  • 1杨淑梅,杨晓梅.CHO-K1细胞中基因瞬时转染的条件优化[J].现代生物医学进展,2009,9(2):265-267. 被引量:3
  • 2Novick D, Rubinstein M. The tale of soluble receptors and binding proteins:from bench to bedside[J]. Cytokine Growth Factor Rev, 2007,18 (5-6): 525-533.
  • 3李军,易小萍,张元兴,孙祥明.瞬时基因表达可溶性的VEGFR2:I-IV[J].生物工程学报,2008,24(5):810-816. 被引量:3
  • 4Derouazi M, Girard P, Van Tilborgh F, et al, Serum-free large?scale transient transfection of CHO cells[J]. Biotechnol Bioeng, 2004,87 (4): 537-545.
  • 5Rosser MP, Xia W, Hartsell S, et. ol. Transient transfection of CHO-KI-S using serum-free medium in suspension: a rapid mammalian protein expression system[J]' Protein Expr Purif , 2005,40 (2): 237-243.
  • 6Baldi L, Hacker DL, Adam M, et al. Recombinant protein production by large-scale transient gene expression in mammalian cells: slate of the art and future perspectives[] J. Biotechnol Lett, 2007, 29 (5): 677-684.
  • 7MuLIer N, Derouazi M, Van Tilborgh F, et ol. Scalable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systems[J]. Biotechnol Lett, 2007,29 (5): 703-711.
  • 8Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer[J]. Nat Rev Drug Discov, 2008,7 (9): 771-782.
  • 9Carpentier E, Paris S, Kamen AA, et al. Limiting factors governing protein expression following polyethylenimine-mediated gene transfer in HEK293-EBNA1 cells[nJ Biotechnol, 2007, 128 (2): 268-280.
  • 10Stettler M, Zhang XW , Hacker DL, et ai. Novel orbital shake bioreactors for transient production of CHO derived IgGs[J]. Biotechnol Prog, 2007, 23 (6): 1340-1346.

二级参考文献26

  • 1吴海涛,胡云龙,陈松,刁振宇,金丽娜,李洁,张双全.重组蛋白在中国仓鼠卵巢细胞中高效表达的影响因素[J].中国生物工程杂志,2004,24(8):1-5. 被引量:11
  • 2MILLER L K. Baculoviruses as gene expression vectors [J]. Ann Rev Microbiol,1998: 42.
  • 3LUCKLOW V A. Cloning and expression of heterologous genes in insect ceils with baculovirus vectors [ C ] // PROKOP C Ho A, BAJPAI R. Recombinant DNA tech- nology and applications, NY: McGraw Hill, 1990:1 - 24.
  • 4DREWS J,RYSER S. Classic drug targets[J]. Nat Biotechnol, 1997 : 1318 - 1319.
  • 5REDAELLI L, ZOLEZZI F, NARDASE V, et al. A platform for high -throughput expression of recombiant human enzyme secreated by insect cells [ J ]. J Biotech, 2005,120:59 -71.
  • 6YAMAJI H, MANABE T, KITAURA A, et al. Efficient production of recombinant protein in immobilihzed insect cell culture using serum-free basal media after baculovirus infection[J]. Biochem Engineering J, 2006, 28:67 - 72.
  • 7AGATHOS S N. Insect cell bioreactors[ J]. Cytotechnology, 1996, 20 : 173 - 189.
  • 8TORINIWA H, KOMIYA T. Japanese encephalitis vires production in Vero cells with serum-free medium using a novel oscillating bioreactor [ J ]. Biologicals, 2007, 35 : 221 - 226.
  • 9LU Jen-te, CHUNG Yao-chi, CHAN Zun-ren, et al. A novel oscillating bioreactor BelloCell: implications for insect cell culture and recombinant protein production [ J ]. Biotechnology Letters,2005, 27 : 1059 - 1065.
  • 10LEE H P, HU Y C. BelloCeU on Text Book [DB/CD ]. http:// www. ceseobio. com. tw,2007.

共引文献7

同被引文献35

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部